Bio-Reference Laboratories has hit a technical signal on 3 different technical indicators. BRLI is in the Health Care sector. The technical signals indicate that the stock is Overbought right now. The 3 indicators: Commodity Channel Index, Relative Strength Index and the Fast Stochastics were all triggered based on the last closing price of $19.52 of 1/26/12. The stock is up 20% year-to-date.
There are currently 6 analysts covering the company. Of these analysts, 4 have a buy recommendation. The current consensus estimate for quarterly earnings among the 6 analysts covering the stock is $0.36 per share. Last quarter the company earned $0.34 per share. The consensus estimate for this years earnings is $1.14 per share as compared to the next years' expectation, of $1.37 per share. The consensus estimate for next years earnings is $1.37 per share, which represents forecast growth of 20.2%.
Over the last 52 weeks, the stock has been trading between $11.41 and $25.99. More recently in the last 4 weeks, the stock has been trading between $15.56 and $19.57. Yesterday the stock traded between $19.00 and $19.57. The stock currently has a PE ratio of 9.9.
Bio-Reference Laboratories is trading 12.6% from its 20-day simple moving average (SMA) of $17.34 and 29.0% from its 50-day SMA and 1.39% from its 200-day SMA. Average daily volume over the last 30 days has been 278,156 shares.
At yesterdays close: the RSI was at 85.0, the CCI was at 162.2 and the Fast Stochastic was at 98.4. BRLI closed yesterday at $19.52, on volume of 264,200 shares as compared to an average volume of 278,156 over the last 4 weeks.
Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. It offers various chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology, and other tissue analysis. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems. In addition, it operates a Web-based connectivity portal solution for laboratories and physicians to provide laboratory ordering and results to physician customers. The company provides its services directly to physicians, geneticists, hospitals, clinics, and correctional and other health facilities. Bio-Reference Laboratories, Inc. was founded in 1981 and is headquartered in Elmwood Park, New Jersey.
Technical Indicators should be used as the starting point for further analysis. These indicators are provided as a guide to help you determine what assets to analyze. The technical indicators used in this article can indicate that an asset is either overbought or oversold, but that indication could be the result of a fundamental or other type of event like an earnings announcement.
To learn more about technical analysis, please refer to our technical analysis primer.
| Porfolios Holding BRLI | Technical Analysis on TheStreet by Fred Meissner |
| TheStreet Ratings Report for BRLI | Read more on Technical Analysis from Tim Collins on RealMoney.com |
| ETFs Holding BRLI |
